• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Global Biosciences Co. Selects ValGenesis VLMS

    Eisai Appoints Chief Clinical Officer of Oncology Biz

    Nexelis Acquires GSK Vax Lab in Marburg

    Bone Therapeutics, Rigenerand Ink Cell Therapy Deal

    NovaQuest Private Equity Acquires CoreRx
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules

    Cognate BioServices Announces Major Expansion

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Global Biosciences Co. Selects ValGenesis VLMS

    Nexelis Acquires GSK Vax Lab in Marburg

    The Future of Clinical Trials Series: Part I

    JS Bio and Etta Biotech Advancing Partnership

    Intravacc Completes Project for Provention Bio’s Vax Candidate
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Aphena Pharma Solutions

    Flow Sciences

    Baxter BioPharma Solutions

    Cytovance Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Syngene

    Alcami

    Aphena Pharma Solutions

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    GRAM, J&J Enter COVID-19 Vax Manufacturing Pact

    GRAM to provide advanced aseptic fill and finish services for supply of J&J’s SARS-CoV-2 vaccine candidate from its facility in Grand Rapids, MI.

    GRAM, J&J Enter COVID-19 Vax Manufacturing Pact
    Related CONTENT
    • Batavia Biosciences and KU Leuven Join Forces
    • Samsung Biologics Breaks Ground on 'Super Plant'
    • Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
    • Dalton Pharma Services Expands Capabilities
    • Argonaut Manufacturing Services Completes First cGMP Run
    Contract Pharma Staff09.25.20

    Grand River Aseptic Manufacturing (GRAM), an injectable contract development and manufacturing organization (CDMO), has entered into an agreement with Janssen Pharmaceuticals, Inc., one of the Companies of Johnson & Johnson, to support the manufacture of its SARS-CoV-2 vaccine candidate.

    The agreement includes the technical transfer and fill and finish manufacture of Johnson & Johnson's SARS-CoV-2 vaccine candidate. Teams from both companies are working to transfer the manufacturing process to GRAM's new, state-of-the-art facility, and are swiftly preparing for the start of vaccine production.

    GRAM is expanding domestic fill/finish capacity for COVID-19 vaccines and therapeutics for companies that have agreements with the federal government to meet its Operation Warp Speed goals. The GRAM expansion is funded, in part, by the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services, in collaboration with the Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND).

    J&J’s vaccine candidate being manufactured at GRAM is being developed, in part, with funding from BARDA which is expected to result in 100 million doses of the investigational vaccine which the federal government will own.

    GRAM is performing advanced aseptic fill and finish services to help ensure that supply of the vaccine candidate would be available upon regulatory approval. GRAM will utilize its 60,000 sq.-ft. large-scale fill and finish facility located in Grand Rapids, MI.

    "Should their vaccine candidate be approved, the opportunity to serve the population with a vaccine to combat the COVID-19 pandemic alongside Johnson & Johnson is an extraordinary privilege," said Tom Ross, President and CEO of GRAM. "Our team is enthusiastic, dedicated and focused on supporting Johnson & Johnson in the fight against COVID-19."

    Related Searches
    • Biologics, Proteins, Vaccines
    Suggested For You
    Batavia Biosciences and KU Leuven Join Forces Batavia Biosciences and KU Leuven Join Forces
    Samsung Biologics Breaks Ground on Samsung Biologics Breaks Ground on 'Super Plant'
    Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
    Dalton Pharma Services Expands Capabilities Dalton Pharma Services Expands Capabilities
    Argonaut Manufacturing Services Completes First cGMP Run Argonaut Manufacturing Services Completes First cGMP Run
    Ramping Up COVID-19 Vaccine Fill and Finish Capacity Ramping Up COVID-19 Vaccine Fill and Finish Capacity
    Thermo Fisher to Expand Sterile Filling Capacity with New Facility in Singapore Thermo Fisher to Expand Sterile Filling Capacity with New Facility in Singapore
    Primary Packaging Considerations Amid COVID-19 Vax Urgency Primary Packaging Considerations Amid COVID-19 Vax Urgency
    Novavax, Par Sterile Products Enter COVID-19 Vax Mfg. Pact Novavax, Par Sterile Products Enter COVID-19 Vax Mfg. Pact
    Evergreen Theragnostics Breaks Ground for Manufacturing Facility Evergreen Theragnostics Breaks Ground for Manufacturing Facility
    J&J Initiates Phase III ENSEMBLE Trial for COVID-19 Vax J&J Initiates Phase III ENSEMBLE Trial for COVID-19 Vax
    Hovione to Support Manufacture of Remdesivir for COVID-19 Hovione to Support Manufacture of Remdesivir for COVID-19
    Samsung Biologics and AstraZeneca Ink Manufacturing Deal Samsung Biologics and AstraZeneca Ink Manufacturing Deal
    PharmAbcine Partners with Samsung Biologics for PMC-403 PharmAbcine Partners with Samsung Biologics for PMC-403
    ARCA Submits IND for AB201 in COVID-19 ARCA Submits IND for AB201 in COVID-19

    Related Breaking News

    • Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Nexelis Acquires GSK Vax Lab in Marburg

      Nexelis Acquires GSK Vax Lab in Marburg

      Enters into a 5-year strategic agreement to support the development of future GSK vaccine candidates.
      Contract Pharma Staff 01.20.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      JS Bio and Etta Biotech Advancing Partnership

      JS Bio and Etta Biotech Advancing Partnership

      Will set up a high titer transient protein expression platform for high quality protein production.
      Contract Pharma Staff 01.19.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
      Intravacc Completes Project for Provention Bio’s Vax Candidate

      Intravacc Completes Project for Provention Bio’s Vax Candidate

      Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.
      Contract Pharma Staff 01.19.21


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Cognate BioServices Announces Major Expansion

      Cognate BioServices Announces Major Expansion

      Will increase cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities and more.
      Contract Pharma Staff 01.15.21

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Thermo Fisher Buys Novasep

      Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

      Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.
      Contract Pharma Staff 01.15.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Precision Medicine Group Acquires Project Farma

      Precision Medicine Group Acquires Project Farma

      Adds Project Farma's unique expertise to Precision's suite of end-to-end cell and gene therapy capabilities to support development and commercialization.
      Contract Pharma Staff 01.14.21


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Cytiva Delivers Modular Biologics Factory to Lonza

      Cytiva Delivers Modular Biologics Factory to Lonza

      Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region.
      Contract Pharma Staff 01.14.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

      Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

      FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.
      Contract Pharma Staff 01.14.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      RheinCell Therapeutics Achieves GMP Certification

      RheinCell Therapeutics Achieves GMP Certification

      Marks a milestone for the evolution of the company.
      Contract Pharma Staff 01.13.21


    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
      Capricor, Lonza Enter CAP-1002 Development Agreement

      Capricor, Lonza Enter CAP-1002 Development Agreement

      Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.
      Contract Pharma Staff 01.12.21

    • Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
      iosBio Inks Exclusive Vax Platform Pact for COVID-19

      iosBio Inks Exclusive Vax Platform Pact for COVID-19

      OraPro oral delivery vaccine platform technology enables oral administration of thermally-stable, viral vector vaccines.
      Contract Pharma Staff 01.12.21

    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
      Adagene Achieves CAR-T Collaboration Milestone

      Adagene Achieves CAR-T Collaboration Milestone

      Yields potential first-ever antibodies targeting human endogenous retrovirus associated with kidney cancer.
      Contract Pharma Staff 01.12.21


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Parenterals
      Irisys Receives NIH Contract for the Formulation of Drinabant

      Irisys Receives NIH Contract for the Formulation of Drinabant

      Seeks to develop a drug for treatment of acute cannabinoid overdose.
      Contract Pharma Staff 01.11.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Parenterals
      Baxter, Novavax Ink Sterile Manufacturing Agreement

      Baxter, Novavax Ink Sterile Manufacturing Agreement

      CMO Baxter will help increase commercial production and promote access to Novavax' Covid-19 vax in UK and European markets.
      Contract Pharma Staff 01.11.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production

      Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production

      Texas A&M System contract designates the CDMO’s Texas facility for emergency federal use.
      Contract Pharma Staff 01.11.21

    Trending
    • Lonza To Exit Pharma Softgels And Liquid-Filled Hard Capsules
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • Grifols Begins COVID-19 Plasma Treatment Trial
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Virtual Clinical Trials: The Future Of Dermatology Studies
    Breaking News
    • Global Biosciences Co. Selects ValGenesis VLMS
    • Eisai Appoints Chief Clinical Officer of Oncology Biz
    • Nexelis Acquires GSK Vax Lab in Marburg
    • Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
    • NovaQuest Private Equity Acquires CoreRx
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ingredient Manufacturers Discuss the E-Sports Market
    Euromonitor Names Top Ten Trends for 2021
    Study Highlights Differences Between EPA's and DHA's Effect on Sleep
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    RSIP Vision Announces Versatile Medical Image Segmentation Tool
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Global Biosciences Co. Selects ValGenesis VLMS
    Eisai Appoints Chief Clinical Officer of Oncology Biz
    Nexelis Acquires GSK Vax Lab in Marburg
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top Beauty Brands in the World—And Most Loved Fragrances
    P&G Reports Q2 Results
    A Lacquering Technique Makes Very Good Girl by Carolina Herrera Shine
    Happi

    Latest Breaking News From Happi

    Flow Launches Collagen Waters
    David Stanko Joins JPMS
    Ross Introduces Double Cone Tumble Blender
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    First Quality Launches Incognito by Prevail
    Essity Launches Reusable Underwear Product
    Honeywell Delivered 225 Million Masks in December
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    DJO Acquires Trilliant Surgical
    FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
    Bioventus Appoints SVP of Operations
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login